Cryoport, Inc.
NASDAQCYRX reports Q1 2026 results tomorrow with the options market signalling unusually strong bullish conviction — the kind rarely seen in a small-cap life sciences name. The clearest positioning signal is the put/call ratio, which is running at just 0.21, near the low end of a 52-week range of 0.01–0.50. That is barely any downside protection relative to upside exposure. The stock has…
Snapshot as of 7 May 2026
CYRX reports Q1 2026 results tomorrow with the options market signalling unusually strong bullish conviction — the kind rarely seen in a small-cap life sciences name. The clearest positioning signal is the put/call…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CYRX — free to start on ORTEX.
Sign up for free →Open CYRX on ORTEX